Latest filing published 29 Mar 2023 for Signify Health, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew S. Holt: trading record in brief
Matthew S. Holt (senior executive) discloses dealings in 3 companies, chiefly Bellerophon Therapeutics, Inc., Signify Health, Inc. and Avantor, Inc. In total, 10 filings cover trades dated from 12 February 2015 to 29 March 2023.
Every open-market trade on record is a purchase: 1 purchase worth €11.3M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants.
The record was last updated on 29 March 2023 with a transaction in Signify Health, Inc. The most recent open-market purchase was published on 23 February 2015, 4,277 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew S. Holt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,672 sharesClass A Common StockSEC:0000899243-23-009919:0
- 14,672 shares0Class A Common StockSEC:0000950103-22-009035:0
- 6,693 shares0Common StockSEC:0001722482-22-000129:0
- 1,215 shares0Common StockSEC:0001722482-22-000090:0
- 7,916 shares0Class A Common StockSEC:0000950103-22-002873:0
- 7,916 shares0Class A Common StockSEC:0000950103-21-002443:0
- 18,232 shares0Common StockSEC:0001600132-16-000045:0
- 460,144 sharesCommon StockSEC:0001104659-15-013148:0
- 460,144 sharesCommon StockSEC:0001104659-15-013148:1
9 of 9 declarations
